BeStock  
Stocks › Biotechnology › INBX

Inhibrx Biosciences INBX

US equityMarket cap rank #3034Biotechnology
$94.56 −$2.43 (-2.51%)
Pre-market · Oct 6, 4:10 am ET · After hours $95.69 +1.20%
Open$97.56
Prev close$96.99
Day range$94.18 – $98.51
Volume207.1K
Market cap$1.39B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership99.5%-9.00 pts vs. prior quarter
Institutions holding198+1 vs. prior quarter
Insider trades (recent)0 buys / 27 sellsNet selling
Short interest23.06% of floatDays to cover 8.3 · as of 15 Sep 2026
Short-sale volume share20.4%5-day average of daily volume

Short-sale volume as % of daily volume

8%18%27%37%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$2.94M (7 inflow days, 13 outflow days).

The five largest holders on file together own 42.3% of shares outstanding.

Largest holders

  • Viking Global Investors LP9.40%
  • Morgan Stanley8.87%
  • Perceptive Advisors LLC8.82%
  • Sanofi7.87%
  • John Kayyem7.30%
  • Mark Lappe6.53%
  • HighTower Advisors, LLC5.92%
  • Bank of America Corporation5.72%

By investor type

  • Mutual Fund32.71%
  • Hedge Fund25.65%
  • Public Company25.61%
  • Individual/Insider15.56%
  • VC/PE Fund10.88%
  • Government Pension Fund2.98%
  • Private Company0.91%
  • Sovereign Wealth Fund0.62%

Reported short interest has fallen from 23.50% to 23.06% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 3,393,511 23.1% 8.3
31 Aug 2026 3,297,743 22.4% 10.4
14 Aug 2026 3,215,230 21.8% 14.4
31 Jul 2026 3,341,210 22.8% 15.6
15 Jul 2026 3,433,872 23.4% 9.0
30 Jun 2026 3,447,032 23.5% 9.9

Discussion

No comments yet — be the first to weigh in on INBX.

Leave a comment

Scroll to Top